214 related articles for article (PubMed ID: 27981425)
1.
Czarnota S; Baxter NJ; Cliff MJ; Waltho JP; Scrutton NS; Hay S
Biomol NMR Assign; 2017 Apr; 11(1):57-61. PubMed ID: 27981425
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of human 108V and 108M catechol O-methyltransferase.
Rutherford K; Le Trong I; Stenkamp RE; Parson WW
J Mol Biol; 2008 Jun; 380(1):120-30. PubMed ID: 18486144
[TBL] [Abstract][Full Text] [Related]
3. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
4. A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT).
Lanier M; Ambrus G; Cole DC; Davenport R; Ellery J; Fosbeary R; Jennings AJ; Kadotani A; Kamada Y; Kamran R; Matsumoto S; Mizukami A; Okubo S; Okada K; Saikatendu K; Walsh L; Wu H; Hixon MS
J Med Chem; 2014 Jun; 57(12):5459-63. PubMed ID: 24847974
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
[TBL] [Abstract][Full Text] [Related]
6. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors.
Ellermann M; Lerner C; Burgy G; Ehler A; Bissantz C; Jakob-Roetne R; Paulini R; Allemann O; Tissot H; Grünstein D; Stihle M; Diederich F; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2012 Mar; 68(Pt 3):253-60. PubMed ID: 22349227
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
Tsuji E; Okazaki K; Isaji M; Takeda K
J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
[TBL] [Abstract][Full Text] [Related]
9. Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.
Zhang L; Jin Y; Chen M; Huang M; Harvey RG; Blair IA; Penning TM
J Biol Chem; 2011 Jul; 286(29):25644-54. PubMed ID: 21622560
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of catechol O-methyltransferase.
Vidgren J; Svensson LA; Liljas A
Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.
Malherbe P; Bertocci B; Caspers P; Zürcher G; Da Prada M
J Neurochem; 1992 May; 58(5):1782-9. PubMed ID: 1560233
[TBL] [Abstract][Full Text] [Related]
13.
Serimbetov Z; Baxter NJ; Cliff MJ; Waltho JP
Biomol NMR Assign; 2017 Oct; 11(2):251-256. PubMed ID: 28866776
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.
Lautala P; Ulmanen I; Taskinen J
Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877
[TBL] [Abstract][Full Text] [Related]
15. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
16. Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase.
Vieira-Coelho MA; Soares-da-Silva P
Brain Res; 1999 Mar; 821(1):69-78. PubMed ID: 10064789
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
Bai HW; Shim JY; Yu J; Zhu BT
Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
[TBL] [Abstract][Full Text] [Related]
18. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
[TBL] [Abstract][Full Text] [Related]
19. Photoactivated linkage of catechol O-methyltransferase and S-adenosyl-L-methionine.
Yu PH
Can J Biochem Cell Biol; 1984 Oct; 62(10):964-9. PubMed ID: 6509362
[TBL] [Abstract][Full Text] [Related]
20. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
